Literature DB >> 2674140

Cytovillin, a microvillar Mr 75,000 protein. cDNA sequence, prokaryotic expression, and chromosomal localization.

O Turunen1, R Winqvist, R Pakkanen, K H Grzeschik, T Wahlström, A Vaheri.   

Abstract

Cytovillin is a microvillar cytoplasmic peripheral membrane protein, with prominent expression in vivo in placental syncytiotrophoblasts and certain human tumors. Cytovillin cDNA was cloned from a human placental lambda gt11 library using affinity purified antibodies. The identity of cytovillin cDNA clones was confirmed by expression of cytovillin in Escherichia coli and using antibodies raised against the expressed fusion protein in comparison with antibodies against cytovillin purified from cultured human choriocarcinoma cells. In these cells Northern blotting analysis identified a major 3.5-kilobase cytovillin mRNA. The cDNA encodes a protein of 575 amino acids corresponding to a molecular weight of 68,084. According to secondary structure prediction, cytovillin is a hydrophilic protein with an extensive internal alpha-helical region ending in a sequence of 7 consecutive prolines. The predicted alpha-helical region showed limited homology to alpha-helical regions of cytoskeletal proteins and certain other proteins, but no extensive homologies were found in the cytovillin cDNA or the deduced amino acid sequence to other registered DNA or protein sequences. Southern blot analysis of a DNA panel of human mouse somatic cell hybrids localized the cytovillin gene to the end of the long arm of chromosome 6 (6q22-q27). Our results show that cytovillin is representative of a novel class of microvillar proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674140

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  PvuII RFLP in the cytovillin gene (VIL2) on human chromosome 6q.

Authors:  R Hauptschein; R Dalla-Favera; G Gaidano
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

2.  Isolation of a cDNA clone encoding a human protein-tyrosine phosphatase with homology to the cytoskeletal-associated proteins band 4.1, ezrin, and talin.

Authors:  Q Yang; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.

Authors:  Shibing Guo; Rui Bai; Wei Zhao; Yuxin Wang; Zhenqun Zhao; Wei Feng
Journal:  Tumour Biol       Date:  2014-01

4.  Three determinants in ezrin are responsible for cell extension activity.

Authors:  M Martin; C Roy; P Montcourrier; A Sahuquet; P Mangeat
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

5.  Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.

Authors:  K D Geiger; P Stoldt; W Schlote; A Derouiche
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 6.  Ezrin Orchestrates Signal Transduction in Airway Cells.

Authors:  Lei-Miao Yin; Ting-Ting Duan; Luis Ulloa; Yong-Qing Yang
Journal:  Rev Physiol Biochem Pharmacol       Date:  2018       Impact factor: 5.545

7.  Eleven novel mutations in the NF2 tumour suppressor gene.

Authors:  D Bourn; G Evans; S Mason; S Tekes; L Trueman; T Strachan
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

8.  Moesin, ezrin, and p205 are actin-binding proteins associated with neutrophil plasma membranes.

Authors:  K Pestonjamasp; M R Amieva; C P Strassel; W M Nauseef; H Furthmayr; E J Luna
Journal:  Mol Biol Cell       Date:  1995-03       Impact factor: 4.138

9.  Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site.

Authors:  R Gary; A Bretscher
Journal:  Mol Biol Cell       Date:  1995-08       Impact factor: 4.138

10.  A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals.

Authors:  D Bourn; S A Carter; D G Evans; J Goodship; H Coakham; T Strachan
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.